Last updated: 2026-09-06 22:45:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Olema Pharmaceuticals, Inc. (OLMA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.75, with a market capitalization of $947.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.99 to $36.26. This page covers its latest market performance, valuation, price trends and company information.
$947.60M | |
$10.61 | |
$60.27 | |
$2.00 | |
$10.73 | |
378.41K | |
-- | |
-- | |
$36.26 | |
$5.99 | |
-- | |
-- |
Olema Pharmaceuticals, Inc. (OLMA) last closed at $10.73 as of 2026-09-04 23:33:00, unchanged from the previous close of $10.73.
During the latest regular trading session, OLMA traded between $2.00 and $60.27, with a volume of 378.41K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Olema Pharmaceuticals, Inc. (OLMA) moved from $10.20 to $10.75, representing a gain of 5.43% ($0.55).
The stock traded between $10.57 and $11.06 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 710.34 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 15.8%
OLMA is currently trading at $10.75, placing it 15.8% of the way from its 52-week low of $5.99 to its 52-week high of $36.26. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 150 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Olema Pharmaceuticals, Inc. (OLMA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.